Adeno-associated virus serotype 1 nucleic acid sequences,...

Details Adeno-associated virus serotype 1 nucleic acid sequences,... Adeno-associated virus serotype 1 nucleic acid sequences,...

2006-09-12

2006-09-12

Guzo, David (Department: 1636)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S363000, C435S366000, C536S023100, C536S023720

Reexamination Certificate

active

07105345

ABSTRACT:
The nucleic acid sequences of adeno-associated virus (AAV) serotype 1 are provided, as are vectors and host cells containing these sequences and functional fragments thereof. Also provided are methods of delivering genes via AAV-1 derived vectors.

REFERENCES:
patent: 5622856 (1997-04-01), Natsoulis
patent: 5871982 (1999-02-01), Wilson et al.
patent: 6027931 (2000-02-01), Natsoulis et al.
patent: 6156303 (2000-12-01), Russell et al.
patent: 6251677 (2001-06-01), Wilson et al.
patent: 6258595 (2001-07-01), Gao et al.
patent: 6274354 (2001-08-01), Wilson et al.
patent: 6365394 (2002-04-01), Gao et al.
patent: 6387368 (2002-05-01), Wilson et al.
patent: 6399385 (2002-06-01), Croyle et al.
patent: 6475769 (2002-11-01), Wilson et al.
patent: 6482634 (2002-11-01), Wilson et al.
patent: 6759237 (2004-07-01), Wilson et al.
patent: 2002/0159978 (2002-10-01), Allen
patent: 2004/0057931 (2004-03-01), Wilson et al.
patent: 2004/0057933 (2004-03-01), Wilson et al.
patent: WO96/13598 (1996-05-01), None
patent: WO98/10086 (1998-03-01), None
patent: WO98/10088 (1998-03-01), None
patent: WO98/11244 (1998-03-01), None
patent: WO99/14354 (1999-03-01), None
patent: WO99/15677 (1999-04-01), None
patent: WO99/15685 (1999-04-01), None
patent: WO99/47691 (1999-09-01), None
patent: WO00/55342 (2000-09-01), None
patent: WO00/75353 (2000-12-01), None
patent: WO01/23001 (2001-04-01), None
patent: WO01/23597 (2001-04-01), None
patent: WO01/40455 (2001-06-01), None
patent: WO01/83692 (2001-11-01), None
patent: WO 02/063025 (2002-08-01), None
patent: WO03/092598 (2003-11-01), None
patent: WO03/093440 (2003-11-01), None
Zhi et al, Increased Antigen-Specific Humoral Response by Adenoviral Vector Prime and Adeno-Associated Viral Vector Boost, Abstract 569, 7thAnnual Meeting of the American Society of Gene Therapy [Jun. 2-6, 2004] Minneapolis, Minnesota (e-publ. May 2, 2004).
Boyer et al, Anti-SARS Humoral and Cellylar Immunity Evoked by Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus, Abstract 558, 7thAnnual Meeting of the American Society of Gene Therapy [Jun. 2-6, 2004] Minneapolis, Minnesota, (e-publ. May 2, 2004).
Gao et al, Clades of Adeno-Associated viruses are widely Disseminated in Human Tissues, Journal of Virology, vol. 78, No. 12, pp. 6381-6388, (Jun. 2004).
Gao et al, Erythropoietin Gene Therapy Leads to Autoimmune Anemia in Macaques, Blood, vol. 103, No. 9, (May 1, 2004).
Rick et al, Congenital Bleeding Disorders, American Society of Hematology, pp. 559-574, (2003).
Surace et al, Delivery of Adeno-Associated Virus Vectors to the Fetal Retina; Impact of Viral Capsid Proteins on Retinal Neuronal Progenitor Transduction, Journal of Virology, vol. 77, No. 14, pp. 7957-7963, (Jul. 2003).
Hauck et al, Generation and Characterization of Chimeric Recombinant AAV Vectors, Molecular Therapy, vol. 7, No. 3, pp. 419-425, (Mar. 2003).
Rabinowitz et al, Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity, Journal of Virology, vol. 76, No. 2, pp. 791-801, (Jan. 2002).
Hauck et al, Characterization of Tissue Tropism Determinants of Adeno-Associated Virus Type 1, Journal of Virology, vol. 77, No. 4, pp. 2768-2774, (Feb. 2003).
Arruda et al, Safety and Efficacy of Factor IX Gene Transfer to Skeletal Muscle in Murine and Canine Hemophilia B Models by Adeno-Associated Viral Vector Serotype 1, Blood First Edition Paper, (Sep. 11, 2003).
E. Rutledge et al, Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2, Journal of Virology, 72(1):309-319 (Jan. 1998).
W. Xiao et al, Gene Therapy Vecotrs Based on Adeno-Associated Virus Type 1, Journal of Virology, 73(5):3994-4003 (May 1999).
H. Chao et al, Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype Vectors, Molecular Therapy, 2(6):619-623 (Dec. 2000).
R. Kotin et al, Site-Specific Integration by Adeno-Associated Virus, Proc. Natl. Acad. Sci. USA, 87:2211-2215 (Mar. 1990).
K. Fisher et al, Recombinant Adeno-Associated Virus for Muscle Directed Gene Therapy, Nature Medicine, 3(3):306-312 (Mar. 1997).
X. Xiao et al, Efficient Long-Term Gene Transfer into Muscle Tissue of Immunocompetent Mice by Adeno-Associated Virus Vector, Journal of Virology, 70(11):8098-8108 (Nov. 1996).
R. Snyder et al, Persistent and Therapeutic Concentrations of Human Factor IX in Mice After Hepatic Gene Transfer of Reocmbinant AAV Vectors, Nature Genetics, 16:270-276 (Jul. 1997).
N. Muzyczka, Use of Adeno-Assicated Virus as a General Transduction Vector for Mamalian Cells, Current Topics in Microbiology and Immunology, 158:97-129, (1992).
R. Samulski et al, Targeted Integration of Adeno-Associated Virus (AAV) into Human Chromosome 19, EMBO Journal, 10(12):3941-3950 (Dec. 1991).
K. Berns, Parvoviridae: The Viruses and Their Republication, in B. N. Fields et al, Fields Virology, 3rded., vol. 2, Chapter 69, pp. 2173-2197 (Lippincott-Raven Publishers, Philadelphia, PA) (1996).
R. Snyder et al, Features of the Adeno-Associated Virus Origin Involved in Substrate Recognition by the Viral Rep Protein, Journal of Virology, 67(10):6096-6104 (Oct. 1993).
K. Berns, Parvovirus Replication, Microbiological Reviews, 54(3):316-329 (Sep. 1990).
R. Samulski et al, Cloning of Adeno-Associated Virus into pBR322: Rescue of Intact Virus from the Recombinant Plasmid in Human Cells, Proc. Natl. Acad. Sci. USA, 79:2077-2081 (Mar. 1982).
J. Chiorini et al, Cloning of Adeno-Associated Virus Type 4 (AAV4) and Generation of Recombinant AAV4 Particles, Journal of Virology, 71(9):6823-6833 (Sep. 1997).
S. Muramatsu et al, Nucleotide Sequencing and Generation of an Infectious Clone of Adeno-Associated Virus 3, Virology, 221:208-217, (1996).
C. Balague et al, Adeno-Associated Virus Rep78 Protein and Terminal Repeats Enhance Integration of DNA Sequences into the Cellular Genome, Journal of Virolgoy, 71(4):3299-3306 (Apr. 1997).
R. Surosky et al, Adeno-Associated Virus Rep Proteins Target DNA Sequences to a Unique Locus in the Human Genome, Journal of Virology, 71(10):7951-7959 (Oct. 1997).
X. Xiao et al, Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous System, Experimental Neurology, 144:113-124 (1997).
Rose et al, Microbiology, vol. 546, pp. 86-92, (1966).
Anderson et al, Nature, vol. 392, pp. 25-30, (1998).
Verma, Nature, vol. 389, pp. 239-242, (1997).
Orkin et al, Report and Recommendations of the Panel to Assess the NIH Investments in Research on Gene Therapy, issue by the National Institute of Health, (Dec. 7, 1995).

Affiliated with

Also associated with

Rating

Adeno-associated virus serotype 1 nucleic acid sequences,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adeno-associated virus serotype 1 nucleic acid sequences,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adeno-associated virus serotype 1 nucleic acid sequences,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3590156